Tag archive for ‘Marc Goodman’
Shiri Habib-Valdhorn On Monday, September 1st, 2014

UBS: Teva hiked Copaxone price 9.9%

– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. –   In the absence of generic competition to its multiple sclerosis treatment Copaxone, Teva Pharmaceutical More...

CFO Eyal Desheh, TEVA
Shiri Habib-Valdhorn On Thursday, December 5th, 2013

Analysts Unenthusiastic Over Teva’s NTE Products

– Teva sees $3 billion in potential sales by 2020 from 50 new therapeutic entities. – Dr. Michael Hayden – 50 new products with $3 billion in potential sales in 2020 is the news delivered More...

Wordpress site Developed by Fixing WordPress Problems